Cinvanti and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cinvanti (aprepitant) and Paclitaxel (paclitaxel). Common drug interactions include anxiety among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cinvanti and Paclitaxel. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Cinvanti?

Cinvanti has active ingredients of aprepitant. eHealthMe is studying from 150 Cinvanti users. Check the latest studies of Cinvanti.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.



On Jul, 30, 2026

13 people who take Cinvanti and Paclitaxel together, and have interactions are studied.

Cinvanti and Paclitaxel drug interactions.

What are the common drug interactions of Cinvanti and Paclitaxel, by gender? *:

female:

  1. Anxiety
  2. Cataract (clouding of the lens inside the eye)
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Dizziness
  5. Drug hypersensitivity
  6. Headache (pain in head)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Hypopnoea (decrease in the breathing rate)
  10. Incontinence (lack of moderation or self-control)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Flushing (the warm, red condition of human skin)

What are the common drug interactions of Cinvanti and Paclitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Flushing (the warm, red condition of human skin)
  2. Dyspnoea (difficult or laboured respiration)
  3. Dizziness
  4. Headache (pain in head)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Hypopnoea (decrease in the breathing rate)
  8. Incontinence (lack of moderation or self-control)
  9. Lethargy (tiredness)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Nausea And Vomiting: 4 people, 30.77%
  2. Ovarian Cancer (cancer of ovary): 3 people, 23.08%
  3. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 15.38%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 15.38%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 15.38%
  6. Asthma: 2 people, 15.38%
  7. Blood Creatinine Increased: 2 people, 15.38%
  8. Constipation: 2 people, 15.38%
  9. Contrast Media Allergy (reaction associated with the use of intravenous contrast material during radiology): 2 people, 15.38%
  10. Dehydration (dryness resulting from the removal of water): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Cinvanti and Paclitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cinvanti and Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cinvanti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cinvanti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant and paclitaxel (the active ingredients of Cinvanti and Paclitaxel, respectively), and Cinvanti and Paclitaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: